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ABSTRACT
Objectives: Having shown previously that an electronic prescription writer and decision
support system improved pediatric prescribing behavior for otitis media in an academic clinic
setting, we assessed whether point-of-care delivery of evidence could demonstrate similar
effects for a wide range of other common pediatric conditions.
Design: Cluster randomized controlled trial.
Setting: A teaching clinic/clinical practice site and a primary care pediatric clinic serving a rural
and semi-urban patient mix.
Participants: A total of 36 providers at the teaching clinic/practice site and eight providers at
the private primary pediatric clinic.
Intervention: An evidence-based message system that presented real-time evidence to
providers based on prescribing practices for acute otitis media, allergic rhinitis, sinusitis,
constipation, pharyngitis, croup, urticaria, and bronchiolitis.
Outcome measures: The proportion of prescriptions dispensed in accordance with
evidence.
Results: The proportion of prescriptions dispensed in accordance with evidence improved
four percentage points, from 38% at baseline to 42% following the intervention. The control
group improved by one percentage point, from 39% at baseline to 40% at trial’s conclusion.
The adjusted difference between the intervention and control groups was 8% (95% confidence
interval 1%, 15%). Intervention effectiveness did not decrease with time.
Conclusion: For common pediatric outpatient conditions, a point-of-care evidence-based
prescription writer and decision support system was associated with significant improvements
in prescribing practices.
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Health information technologies offer substantial promise to
improve health care [1]. Electronic medical records (EMRs),
decision support systems (DSSs), and computerized provider
order entry (CPOE) offer the potential to reduce practice
variation, improve access to patient data, increase efﬁciency
of documentation, provide decision support for practi-
tioners, and deliver educational materials to patients [2]. In
studies involving hospitalized adults, CPOE systems have
reduced errors; increased accuracy, readability, and com-
pleteness; facilitated decision support; and reduced costs [3–
18].
In one outpatient setting with a comprehensive EMR
system, provider management decisions and choice of
medications were inﬂuenced by alerts for routine screening,
for abnormal physical examination parameters, and for
potential medication side effects [19–22]. Many other studies
that have evaluated the impact of EMR systems in the
outpatient setting have focused on the use of computer-
generated provider or patient reminders to improve pre-
ventive care services, and have demonstrated a varying range
of results [23–31]. However, systematic reviews of studies that
have assessed computerized DSSs providing reminders and
feedback to health-care providers (HCPs) have shown them to
make relatively modest improvement in prescribing practices
[32,33].
In pediatrics, CPOE with DSS has reduced errors in the
treatment of seriously ill, hospitalized children. In Tennessee,
medication prescribing errors in a critical care unit fell from
a rate of 30 per 100 orders to 0.2 per 100 orders after
implementation of CPOE [14]. In Salt Lake City, Utah,
implementation of an anti-infective decision support tool
in a pediatric intensive care unit reduced the rate of drug
prescribing errors requiring pharmacist intervention by
more than half [34]. Computer-based documentation has
also been shown to improve the delivery of pediatric
preventive services [2,35]. Nevertheless, even though 61.2
million visits each year are made by children to physicians in
the ofﬁce-based setting, and 26% of these visits result in an
antibiotic prescription [36], adoption and dissemination of
CPOE with DSS has been slow. There are many reasons for
this, but at least some of the reasons are that the cost of these
systems can be substantial, while the feasibility and effective-
ness of CPOE and/or decision support in the ambulatory
pediatric setting are largely unknown.
We previously demonstrated the ability of an electronic
prescription writer and DSS to improve pediatric prescrib-
ing behavior for otitis media in an academic clinic setting
[37]. Using a ‘‘homegrown’’ DSS we were able to demonstrate
a 34% greater reduction in prescribing for otitis media
among providers given evidence-based messages at the time
of prescription writing compared to providers not given
such messages. These ﬁndings led us to address the question
of whether such a system could demonstrate a similar effect
for a wide range of other common conditions typically seen
by pediatricians, and equally important, whether such a
system could work in a community-based, nonacademic
practice setting. In this paper we present the results of a
cluster randomized clinical trial designed to answer these
questions.
Editorial Commentary
Background: Computerized systems for managing health-care infor-
mation, such as medical records and prescriptions, have the potential to
improve medical care. These improvements could come about as a result
of embedding software within a medical record system that alerts
clinicians to evidence that is relevant to the care they are providing. For
example, such a system might deliver a pop-up reminder that informs a
clinician about a potential prescribing error, or that the prescription
ordered is not supported by recent evidence. Systematic reviews of
randomized controlled trials evaluating the benefits of such systems
have shown that computerized feedback and reminder systems can
improve clinician behavior. However, much of this evidence comes from
academic clinics caring for adults, and there is not very much evidence
available on children or from community-based, nonacademic clinical
practices. The researchers here wanted to evaluate whether a
computerized system providing clinical decision support at the time of
electronic prescribing could improve prescribing in pediatric primary
care. In order to test this, the researchers carried out a cluster
randomized trial. This means that individual health-care providers were
randomized to receive evidence-based prompts via the computerized
system or not, depending on which arm of the trial they were
randomized to, but outcome data for the trial were collected at the level
of the individual patient’s prescription. Pop-up prompts were provided
for eight medical conditions common in pediatric primary care, and
alerted the provider to a summary of the evidence that supported or
refuted the prescription that the provider was about to make. The
primary outcome in the trial was the change in proportion of
prescriptions dispensed in accordance with evidence, over the course of
the trial.
What the trial shows: In the trial, 36 pediatric health-care providers
were randomized at one site, where the trial was carried out over 50
months, and eight at another, where the trial lasted for 18 months. At
the start of the trial, 38% of prescriptions in the intervention group were
in accordance with the evidence, and 39% of prescriptions in the control
group. At the end of the trial, 42% of prescriptions in the intervention
group were in accordance with evidence, as compared to 40% of
prescriptions in the control group. The difference in prescribing behavior
change over the course of the trial between intervention and control
groups was statistically significant, once adjusted for the clustering of
data by the individual providers.
Strengths and limitations: In this trial, health-care providers were
randomized, rather than patients. This method (cluster randomization) is
probably the most appropriate method to carry out a trial such as this,
because it reduces the chance of contamination (i.e., that patients not
assigned to the intervention might receive some of its benefits). One
limitation is the small number of providers that were recruited into the
trial; another is that many of these in fact practiced or had recently
practiced in academic medicine rather than community-based, non-
academic clinical practices. This limits the ability to generalize from these
findings to a nonacademic setting. Finally, the trial was planned with the
intention of evaluating the ability of computerized systems to achieve
health-care provider behavior change. Therefore, data were analyzed by
lumping together outcomes for many different medical conditions. This
means that the computerized prompt system may not necessarily have
been that successful in achieving improvements in prescribing for any
individual condition.
Contribution to the evidence: Systematic reviews of the effectiveness
of computerized decision support systems of this kind have found some
evidence that such systems can improve the behavior of health-care
providers. This study adds data showing that the reminder system
studied here resulted in moderate improvements in prescribing within a
pediatric primary care setting.
The Editorial Commentary is written by PLoS staff, based on the reports of the
academic editors and peer reviewers.
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Design
This was a cluster randomized clinical trial of provider
behavior change. We measured prescribing behavior in both
the intervention and control groups before and after the
introduction in the intervention group of a DSS providing
evidence at the time of electronic prescribing. This approach
enabled us to measure the independent effects of the
intervention, while controlling for baseline differences in
prescribing behavior and other temporal trends unrelated to
our intervention.
In this study the unit of intervention was the provider. We
chose this design because a cluster randomized clinical trial is
the strongest study design available to assess the effect of a
DSS upon provider behavior, as it directly compares
providers receiving the intervention to those not receiving
the intervention. Direct contamination between providers
was likely to be minimal because, as detailed below, the DSS
provided privately viewed messages that only brieﬂy engaged
the practitioners and their patients. Had we randomized
patients instead, it would have resulted in providers taking
care of both patients receiving the intervention and others
not receiving the intervention, with the strong possibility of
diluting the intervention effect.
Setting
This study was conducted at two clinical sites. One was the
Pediatric Care Center at the University of Washington (PCC),
an outpatient teaching clinic for pediatric residents and a
clinical practice site staffed by full-time pediatric providers.
The other site was Skagit Pediatrics (SP), a primary care
pediatric clinic serving a rural and semi-urban patient mix
approximately 60 mi north of the Seattle metropolitan area.
At the start of the study period at PCC, care was provided
by 29 resident physicians, two nurse practitioners, and seven
attending physicians, each with their own patient panels. At
SP, there were eight physicians and two nurse practitioners,
also each with their own patient panels. Both clinics adopted
a computerized patient ﬂow manager developed by one of us
(JAW); this system was described in detail in our earlier
publication [35]. At PCC, a computer workstation was placed
in physician work areas and nursing stations and connected
to a server via a local area network. At SP, because of limited
space availability in exam rooms, providers were equipped
with wireless handheld computers (either personal digital
assistants or pen-based tablet computers) connected via the
local area network to a server.
An electronic prescription writer was developed to inter-
face with the computerized patient ﬂow manager. To
prescribe a medication, a provider ﬁrst selected the patient’s
name and then the patient’s medication, indication, dosage,
and, ﬁnally, the duration. The patient’s weight was entered by
the nurse during check-in. A paper copy of the prescription
was printed for the patient and was also attached to each
medical record.
Providers were trained on the network, and then a 6-mo
period prior to randomization was used at each site to collect
baseline prescribing behavior for all providers. When the
intervention started, paper prescriptions were either re-
moved (at PCC) or actively discouraged (at SP).
Participants
The participants in the study were the 36 HCPs at PCC and
the eight HCPs at SP (Figure 1). Study investigators at each
site were excluded from participation. The protocol for both
sites was approved by the University of Washington Institu-
tional Review Board. Consent to participate in the study was
given by the providers; individual consent from patients was
not required.
Randomization
At each site, the unit of randomization was the HCP. We used
a stratiﬁed randomization process to randomly assign
providers to either the intervention arm or the control
arm. Speciﬁcally, for each condition (otitis media, croup,
etc.), providers were ﬁrst stratiﬁed by the number of
prescriptions they wrote in the baseline period, in order to
roughly equalize the number of patients seen by providers
and prescriptions written in the intervention and control
arms. Then, within strata of high or low number of
prescriptions written, HCPs were randomly assigned to
receive evidence-based medicine prompts or not. In both
clinics, providers could have been randomly assigned to
receive anywhere from none to all of the evidence-based
prompts; after randomization it turned out that all providers
received at least one evidence-based prompt.
Random numbers for allocation were generated by com-
puter, and were concealed until interventions were assigned.
This process was overseen by the research coordinator (L. L.)
in conjunction with the investigator in charge of the data
structure (J. W.). L. L. enrolled participants and assigned
participants to their groups based on the randomization.
Participants were not informed in advance of the study as to
which conditions were being investigated, and hence were
blinded to the intervention. However, based on the nature of
the intervention, HCPs were (theoretically) able to determine
to which evidence screens they were randomized by dis-
cussions with other HCPs.
In 2000 and 2001, additional residents were randomized as
they joined PCC as interns. After baseline data collection for
these residents, they were randomized as the others to either
the intervention or control groups, and then followed in the
same manner as the other providers until study conclusion.
Interventions and Conditions Studied
For each condition studied, providers in the treatment arm
were shown pop-up ‘‘alert’’ screens, based on their selection
of medication, indication, or duration. The ﬁrst screen
contained a short summary of the evidence either supporting
or refuting the current choice of medication, indication, or
duration. The provider could then choose to (i) view more
information about this evidence, (ii) view the abstract of the
article from which the evidence was derived, (iii) view a
scanned PDF version of the article, or (iv) have the reference
E-mailed to them for later viewing. Table 1 shows examples of
the ﬁrst screens shown to providers for otitis media and
allergic rhinitis (a screenshot of how this message appeared is
shown in Figure S1). In the vast majority of cases, providers
did not venture past the ﬁrst screen during the process of
writing a prescription.
The conditions included in the intervention were acute
otitis media, allergic rhinitis, sinusitis, constipation, phar-
yngitis, croup, urticaria, and bronchiolitis. For the outcome
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previously published in the earlier report by Christakis et al.
Excluding these data did not affect our results or conclusions,
and we have elected to include these data so that we are able
to address the consistency of effect among the two inter-
vention sites. The full details of the information provided in
the evidence screens are available from the authors.
Outcomes
Main analysis. Our primary outcome was changed physi-
cian behavior in accordance with the intervention message
screens. Our primary measure assessed all of the interven-
tions considered together, in order to answer the question,
‘‘Can we inﬂuence provider prescribing behavior by provid-
ing ‘just-in-time,’ evidence-based prompts?’’ We also looked
at the effect of the message screens upon the separate
outcomes of (i) otitis media, (ii) allergic rhinitis, and (iii) a
combined category of the other (less common) conditions.
These categories were chosen a priori, as these conditions
were the ones found to be most frequently evaluated in the
clinic during the study planning stages (and were not
necessarily the conditions for which medications were most
frequently later prescribed). All analyses were performed by
‘‘intention to treat.’’
Bronchiolitis was studied separately. This was necessary
because the ‘‘baseline’’ period (used for randomization and to
measure change from baseline) did not include the most
recent past bronchiolitis season, and hence change from
baseline could not be measured in the analysis. Instead, for
bronchiolitis we compared the behavior of providers receiv-
ing the intervention directly to the behavior of control
providers.
Subanalyses. We performed two subanalyses. In our ﬁrst
subanalysis we added a ‘‘one click’’ option for allergic rhinitis
and otitis media that allowed a provider to rapidly accept a
pre-written electronic prescription corresponding to the
‘‘correct’’ message presented on the screen. For example, a
provider attempting to prescribe diphenhydramine for
allergic rhinitis received an evidence-based alert screen
recommending ﬂuticasone for this indication. In the original
intervention, a provider wishing to change from diphenhydr-
amine to ﬂuticasone would have had to close out the alert
screen, cancel the diphenhydramine prescription, and then
begin the ﬂuticasone prescription. With the one-click option,
Figure 1. Recruitment, Randomization, and Analysis of Providers in Study
doi:10.1371/journal.pctr.0020025.g001
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the alert page and the diphenhydramine prescription, and
automatically completed a weight-based ﬂuticasone prescrip-
tion. This one-click option was estimated to save each
provider approximately 11 keystrokes or mouse clicks for
each prescription dispensed.
Our second subanalysis studied whether or not the
intervention effectiveness faded over time, even with con-
tinued alerts. To assess whether providers were tiring of the
intervention, we divided the time following the beginning of
the intervention into ﬁve quarters (3-mo periods) following
the introduction of the intervention; within each time period,
the intervention effect was otherwise assessed exactly as in
the main analysis. Dividing the study in this way allowed us to
see whether the effect waned over the period of the study,
and to test whether providers might be paying less attention
to the intervention with repeated exposure over time.
Statistical Analysis
As in the original study, provider behavior change was
measured as the difference, by study arm, between the
outcomes in the period before and after the trial (except
for bronchiolitis, as mentioned above). Measuring each
provider’s behavior as a change from baseline served two
functions. First, it controlled for each provider’s individual
prescribing practices, and second, it reduced the random
variance in the outcome measure, affording our analysis
greater power. Because we measured the outcomes as a
change in individual behavior, it was not necessary to control
for provider-speciﬁc potential confounders. To test the
primary hypothesis we used weighted regression analyses,
controlled for clustering by provider, to test the difference in
behavior change between the treatment and control groups.
Weighted regression analyses, again controlling for clustering
by provider, were also used to assess the statistical signiﬁ-
cance of the behavior change within the treatment and
control groups.
The provider panels were unbalanced because of different
work styles and schedules, and some providers had many
more visits than others. As a result, the outcomes (mean
change in provider behavior) were estimated with a greater
degree of precision for providers with many visits than for
providers with fewer visits. To account for this in the
regression analyses, we conducted weighted analyses, whereby
each provider’s behavior contributed information to the
analysis proportional to the precision with which their mean
was estimated. As in the original analysis, this method
achieved greater precision in the intervention estimates than
unweighted analyses.
Not all providers treated patients for each randomized
intervention during both the before and after period, and
therefore, the number of providers contributing information
to each intervention varied slightly.
All analyses were conducted with Stata, version 6.0,
statistical software (Statacorp,http://www.stata.com).
Sample size. The number of providers available to
participate in this study was estimated a priori to be
approximately 42. We calculated the power of the study
adjusted for clustering effects using the method of Hayes and
Bennett [38]. At the time the study was conceived, approx-
imately 75% of otitis media cases were being treated with
antibiotics, and we considered a clinically signiﬁcant goal to
be that of lowering this proportion to 60%—an absolute
change of 15%. With 42 providers, we calculated that this
treatment effect could be detected with 90% power with
alpha ¼ 0.05, assuming a standard deviation of 15% across
providers.
RESULTS
General Descriptives
The intervention period lasted for a total of 50 mo at PCC
(from November 1999 to December 2003) and for 18 mo at SP
(from June 2002 to December 2003), during which 57,319 and
33,127 visits were made for pediatric care at the two sites,
respectively. (The length of the intervention was longer at
PCC since the network was already in place at PCC while it
had to be constructed at SP.) At the two sites combined there
..........................................................................................................................................................................................
Table 1. Example Summaries of Actions Triggering First-Level Evidence Screen for Two Selected Conditions
Condition Prescription (Action) First Screen Message
Acute otitis media Amoxicillin, ampicillin, or azithromycin for otitis media ‘‘You need to treat 22 children with antibiotics in order to relieve one additional
case of otalgia within 2–7 days. For every additional case of otalgia relieved, 1 to
3 children will experience antibiotic related diarrhea.’’
Any duration of amoxicillin beyond 5 d ‘‘At 8–19 days after the initiation of therapy, only 1 child out of 19 would show
additional benefit from a 10-d course of antibiotics beyond what would be ex-
pected from a 5-d course. At 30 days, there is no difference in the success of 10-
d versus 5-d courses of antibiotics.’’
Any antibiotic other than amoxicillin ‘‘Available data suggest that no antibiotic is more effective than amoxicillin as a
first-line therapy for otitis media.’’
Amoxicillin 30–35 mg/kg ‘‘40 mg/kg of amoxicillin has been shown to be an effective dose for treating oti-
tis media. There are no data suggesting that doses less than this are effective.’’
Amoxicillin three times daily ‘‘Amoxicillin can be dosed twice daily based upon the reported efficacy of twice
daily amoxicillin/clavulanate dosing studies in AOM. The presence of clavulanate
does not change the pharmacokinetics of amoxicillin, except in the presence of
beta-lactamase positive bacteria.’’
Allergic rhinitis Loratadine for allergic rhinitis ‘‘Although no data is available in children, in adolescents intranasal steroids (fluti-
casone) were more effective than oral loratadine (Claritin)—more symptom free
days & less nasal congestion were found with intranasal steroids.’’
AOM, acute otitis media.
doi:10.1371/journal.pctr.0020025.t001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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acute sinusitis, 372 for allergic rhinitis, 235 for pharyngitis, 96
for croup, 85 for urticaria, 79 for bronchiolitis, and seven for
constipation. The baseline rates of prescribing in accordance
with the evidence are shown in Table 2; during baseline, the
percent of prescriptions that were prescribed in accordance
with the evidence were 38% and 39% in the intervention and
control groups, respectively.
Main Analyses
For the primary outcome of our study—all condition-speciﬁc
outcomes assessed as a single group—the intervention had a
statistically signiﬁcant effect upon provider prescribing
behavior (Table 2). Among providers not receiving the
intervention, prescribing behavior in accordance with the
evidence improved only marginally, by 1%, while among
those receiving the intervention, prescribing behavior im-
proved by 4%. The crude absolute difference in these
behavior changes was 3%; the adjusted effect size was 8%
(95% conﬁdence interval 1%, 15%). This effect remained
signiﬁcant even after excluding the outcome of otitis media
from PCC.
Looking at the conditions separately (Table 3), providers
receiving the intervention at PCC showed statistically
signiﬁcant differences in the decision to treat otitis media
and in their choice of medication for treatment of allergic
rhinitis. They also showed improvements in the ‘‘combined’’
group of diagnoses, although this change was not statistically
signiﬁcant. At SP, the intervention group showed statistically
signiﬁcant improvements in the decision to treat otitis media.
Interestingly, as we found in the original trial, at each site
there was a secular trend towards increased treatment of
otitis media with antibiotics, and our intervention served
primarily to slow this trend among those providers receiving
the evidence screens.
For bronchiolitis, providers in the intervention group at
PCC prescribed albuterol for bronchiolitis substantially less
often than providers in the control group (21% versus 32%,
respectively; absolute difference of 11%; adjusted effect size
of  6% [95% conﬁdence interval  18%, 7%]). At SP the rate
of prescribing for bronchiolitis was so low (one prescription
for albuterol during the study period) as to preclude analysis.
Subanalyses
In the one-click option subanalysis, there was little evidence
that this option further impacted provider behavior. There
was no signiﬁcant change or improvement in prescribing for
either otitis media or allergic rhinitis at either PCC or SP
when the one-click option was added to the screens for
providers already receiving the intervention. For example, at
PCC prescribing amoxicillin twice daily for otitis media
increased by 2%, while proper dosing for otitis media fell by
2%.
In the second subanalysis, we found little evidence of
provider fatigue. For one condition—otitis media—the
impact of the intervention was rather weak for the ﬁrst two
quarters of the intervention, but then demonstrated a
markedly improved impact over the next three study quarters
(9% less prescribing in the intervention group compared to
the control group for otitis media in quarters 1 and 2, and
26%–27% less prescribing during quarters 3–5). When we
looked at all conditions combined, the intervention demon-
strated some variability but overall had a constant effect over
the study.
DISCUSSION
Interpretation
In the Institute of Medicine report ‘‘Crossing the Quality
Chasm’’ [1], the Committee on Quality of Health Care in
America outlined a number of strategies for improving the
quality of health care in the United States, including the
redesign of care processes to reﬂect best practices and the use
of information technologies to improve access to clinical
information and to support clinical decision-making [8]. In
our cluster randomized trial of using information technology
to deliver evidence to pediatric providers at the time of
prescription writing, we found an overall modest, yet
statistically signiﬁcant improvement in provider prescribing
practices. The impact of the electronic prescription writer
took some time (as opposed to having an immediate effect),
and continued exposure to the message screens was necessary
to maximize desired prescribing behaviors for some speciﬁc
conditions such as otitis media.
There was considerable variation in the degree of effect of
the intervention based on which message screen was being
viewed. This is not surprising as the messages themselves
differed in the strength of their recommendations. A key
feature of the system (which distinguishes it from many
previous interventions) was that the evidence-based support
system was nether prescriptive nor proscriptive. The mes-
sages were developed from the best available evidence, which
..........................................................................................................................................................................................
Table 2. Summary of Behavior for All Outcomes across Sites
Outcome Control
Group
Intervention
Group
Adjusted Difference in Behavior
Change, Intervention versus Control
Number of patient visits 5,877 6,318
Percent of prescriptions in accordance
with evidence at baseline
39% 38%
Percent of prescriptions in accordance
with evidence at conclusion
40% 42%
Percent change in behavior
a 1% 4% 8% (95% confidence interval 1%, 15%)
Outcomes were acute otitis media, allergic rhinitis, sinusitis, constipation, pharyngitis, croup, and urticaria. (Bronchiolitis was studied separately; see text for further details.)
aPercent change in behavior refers to the absolute difference (in percentage points) in prescribing behavior between the baseline period and the study period (a positive number reflects
improvement in prescribing behavior). Data shown represent individual-prescription-level data. To test the primary hypothesis we used weighted regression analyses, controlled for
clustering by provider, to test the difference in behavior change between the treatment and control groups.
doi:10.1371/journal.pctr.0020025.t002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Ambulatory Pediatrics Cluster Randomized Trialwas frequently limited. In a few cases, the only evidence came
from adolescent and adult studies, and providers had to
decide if the study conclusions were applicable to children.
Some of the messages included a ‘‘number needed to treat,’’
and providers likely weighed this information differently
based on individual patient preferences, the condition being
treated, and the severity of the condition at the time of
presentation. This approach attempted to empower pro-
viders with information, and was in keeping with recom-
mendations for applying evidence to practice [39–41], but it
may have been less likely to alter behavior than a purely
directive approach. While others have proposed using group
consensus to create guidelines in the absence of clear
treatment recommendations [42], we believe that this would
have been counter to our intent to facilitate the use of
evidence-based medicine. Another key element of our
intervention was that it was integrated into practice in such
a way as to present relevant information to providers at the
point of care without disrupting workﬂow. Rapid access to
information at the point of care may be key for changing
provider behavior [32], but it is hard to accomplish in a busy
clinical setting.
There were some limitations to our trial. First, only eight
of the 44 providers we studied practiced outside of an
academic training environment, limiting our ability to make
inferences about the performance of this system in the
general practice arena. Second, because of power limitations,
we were unable to assess whether the evidence screens may
have had different effects for clinicians at different levels of
training. Finally, we speciﬁcally planned to study the ability
of electronic point-of-care systems to effect physician
behavior change, not the effectiveness of an electronic
point-of-care system to deliver messages about a single
condition. This required that, for our main outcome, we
considered all behavior change to be of merit and of equal
importance statistically. Such an assumption, while necessary
for our study, might not necessarily be well founded. It may
be that we would have observed stronger effects and more
robust ﬁndings had we focused on only one or two outcomes
and employed a more comprehensive and concentrated
intervention geared towards effecting management change
within these conditions. In this regard, future evaluations
might focus on trying to effect behavior change for some
particular conditions that, for example, drive a large
proportion of health-care costs, or are associated with
substantial need for prescribing improvement.
While for many conditions prescribing behavior improved,
we found that antibiotic prescribing for otitis media
increased for providers in both the intervention and
controlgroups, counter to the evidence provided in the
intervention. Our intervention served primarily to slow the
tide towards increased prescribing. This increase in prescrib-
ing occurred even though recent publications included in the
intervention evidence supported limiting antibiotic use
[43,44], and the 1999 Washington State Department of
Health’s ‘‘Practice Guidance for the Judicious Use of Anti-
biotics in Otitis Media’’ [45] included a recommendation for
observation and symptomatic treatment alone in patients
with mild symptoms. We do not have a good explanation for
this trend in behavior, although because we recorded only
prescriptions written as opposed to prescriptions ﬁlled, it is
possible that providers were writing some prescriptions but
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to improve without antibiotics.
Our subanalyses unveiled some important ﬁndings rele-
vant to future implementation of these systems. We found
that for some conditions there was a delay before the
message screens achieved their fullest impact. Technological
problems early in the study may have decreased early
adoption of the system, or alternatively, providers may have
needed time and repeated exposure to the evidence-based
messages before they changed their behavior, especially
behavior most ingrained such as for otitis media. The
second subanalysis assessed our attempt to streamline
electronic prescribing. Previous investigators have reported
that ease, speed, and some control of the system is crucial to
the successful adoption of a clinical support system [46–50],
but we saw little impact from a one-click option that
reduced keystrokes. This one-click option was introduced in
the latter half of the study, and it may be that the
intervention had already achieved its maximal effect in
changing prescribing practices. In addition, providers al-
ready facile with the system and viewing message screens
quickly could have failed to notice this additional feature
when it appeared.
Generalizability
An assessment of the generalizability of our ﬁndings is
critical. One of our two sites was situated within a large
academic medical center, while the other clinic was
populated by many recent graduates of this same site.
Additionally, the practices served a fairly well-educated and
primarily English-speaking urban and semi-urban patient
population. Hence, our ﬁndings might not be generalizable
to pediatric practices that differ in meaningful ways either in
terms of their patient demographics or provider practice
patterns.
Additionally, the computer software that was developed
and used for this trial was independent from any other
computer system in place in these clinics, and was unattached
to any other computerized messaging systems. Uptake of
systems in other settings might indeed be different, especially
if an entire suite of messages is provided that is designed to
provide evidence and other information oriented towards
improving delivery of care.
With regards to this last point, our ﬁndings are particularly
pertinent to smaller clinical practices that might not be
aligned with larger organizations, and who will have to choose
EMR systems and DSSs on their own. During our trial we had
a number of challenges related to computer software and
hardware, and other studies have reported likewise [51,52].
For example, battery life for the wireless equipment was
problematic, especially during the early days of the study, and
numerous adjustments were required to solve this problem.
Ideally, complex interventions should be ﬁrst developed
through an interactive process, and evaluations should be
performed on stable systems [53,54]. However, this is easier
said than done in the course of a clinical trial of a health
technology, not just because of the practical time constraints
of trial funding, but also because systems and technology
continually change, improvements in software and hardware
may cause other unforeseen, new problems, and the needs
and wants of providers for particular features change over
time. As electronic information systems become more wide-
spread, rapid evaluation will be important in order to better
understand the impact of electronic decision support on
provider behavior [54].
We found that initial on-site training of all providers was
insufﬁcient to ensure ongoing use of the system, and use was
not habitual until after providers had used the system for
many months. We offered labor-intensive support with on-
site promoters, research assistant presence, E-mail hints, and
person-to-person rather than simply electronic feedback
mechanisms—all among the recommended strategies for
improving adoption of health technology applications
[55,56].
Our effect size compares favorably to other considerably
more intensive and expensive interventions [57–59] and has
two distinct advantages. First, once the ﬁxed costs of an EMR
system are accounted for, the marginal costs of DSS are small.
Second, if a stable system is in place, upgrades can be done to
incorporate new evidence or other features.
Overall Evidence
Any comparison of our ﬁndings to those of others must ﬁrst
recognize that there have been many different types of
computerized medication management systems developed.
Bennett and Glasziou [32] categorized these systems accord-
ing to their type—provider reminders in outpatient settings,
provider feedback, combined reminders and feedback,
inpatient reminders, and patient directed reminders—and
the intended setting, and presented a review of their
effectiveness. Reminders differ from feedback in that the
former refer to information delivered around the time of the
encounter and directed towards a speciﬁc episode of care,
while the latter refers primarily to aggregated information
collected on patients or providers and delivered with the
intent of affecting future clinical care decisions. Following
Bennett and Glasziou’s scheme, our trial is most comparable
to a total of 11 other trials that have assessed provider
reminders in outpatient settings. Of these 11, the evidence is
quite divided in terms of showing effectiveness: ﬁve of the
studies showed positive effects while six did not. Among the
studies showing positive effects, three had relatively small
effect sizes that were consistent with what we found in
general. However, none of these 11 studies were performed
on pediatric populations, making further inferences or
comparisons problematic.
It is important to recognize that we studied only a part of
the capabilities of this (or similar) systems. An 8% overall
improvement in prescribing practices such as we found, along
with other point-of-care interventions such as guidelines for
chronic care, could have substantial long-term impacts, for
example, on reducing antibiotic resistance or costs of care.
Nevertheless, the challenge is to continue to improve the
efﬁciencies of these systems. A recent study of computerized
decision support in primary care found no effect of its
guideline-based interventions due to low levels of use [60].
Given the current complexity of medical practice and the
rapid pace of advancements in medical science, we believe
that clinicians are overloaded with information and need
these systems if their decision-making is to be evidence based
[52,60]. Work is needed to provide better integrated, more
robust, and more ﬂexible products that meet providers’
needs.
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